Fifth, it has been demonstrated that inhibiting both AKT1 and AKT2 is essential for obtaining a greater sensitization of tumor cells to apoptotic stimuli and reduceing AKT phosphorylation in vivo [88,89]. The gene discussed is AKT2; the disease is neoplasm.